364621-46-5
364621-46-5
Chemical Structure
TFCP2L1-IN-1
- CAS No.: 364621-46-5
- Formula:C15H13BrN2OS
- Molecular Weight:349.25
InChIKey: HEGLZZCJRVMIDM-UHFFFAOYSA-N
SMILES: BrC1=CC=CC(C(NC(NC2=CC=CC=C2C)=S)=O)=C1
Biological Activity: TFCP2L1-IN-1 is a specific small molecule targeting TFCP2L1’s active domain with anti-cancer activity. TFCP2L1-IN-1 synergizes with Sorafenib (HY-10201) to induce Apoptosis and reduces cell proliferation, invasion, metastasis, clonal formation and sphere-forming capacity in hepatocellular carcinoma cells[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TFCP2L1-IN-1 | 99.66% | TFCP2L1-IN-1 is a specific small molecule targeting TFCP2L1’s active domain with anti-cancer activity. TFCP2L1-IN-1 synergizes with Sorafenib (HY-10201) to induce Apoptosis and reduces cell proliferation, invasion, metastasis, clonal formation and sphere-forming capacity in hepatocellular carcinoma cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
